Simultaneous recognition of HIV-1 TAR RNA bulge and loop sequences by cyclic peptide mimics of Tat protein
暂无分享,去创建一个
Gabriele Varani | John A. Robinson | Thomas C. Leeper | Jonathan Karn | Amy Davidson | J. Karn | G. Varani | T. Leeper | Z. Athanassiou | Amy Davidson | Krystyna Patora-Komisarska | Zafiria Athanassiou | Krystyna Patora-Komisarska
[1] S. Grzesiek,et al. NMRPipe: A multidimensional spectral processing system based on UNIX pipes , 1995, Journal of biomolecular NMR.
[2] Patel,et al. Molecular recognition in the bovine immunodeficiency virus Tat peptide-TAR RNA complex. , 1995, Chemistry & biology.
[3] J. Karn,et al. High affinity binding of TAR RNA by the human immunodeficiency virus type-1 tat protein requires base-pairs in the RNA stem and amino acid residues flanking the basic region. , 1993, Journal of molecular biology.
[4] J. Karn,et al. An inhibitor of the Tat/TAR RNA interaction that effectively suppresses HIV-1 replication. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[5] A. Frankel,et al. Dissection of the proposed base triple in human immunodeficiency virus TAR RNA indicates the importance of the Hoogsteen interaction. , 1997, Biochemistry.
[6] John A. Robinson,et al. TAR RNA recognition by a cyclic peptidomimetic of Tat protein. , 2005, Biochemistry.
[7] T. Rana,et al. Controlling human immunodeficiency virus type 1 gene expression by unnatural peptides. , 1999, Biochemistry.
[8] J. Puglisi,et al. Solution Structure of a Bovine Immunodeficiency Virus Tat-TAR Peptide-RNA Complex , 1995, Science.
[9] E. De Clercq,et al. The regulation of HIV‐1 transcription: Molecular targets for chemotherapeutic intervention , 2006, Medicinal research reviews.
[10] J. Karn,et al. Tackling Tat. , 1999, Journal of molecular biology.
[11] John A. Robinson,et al. Structure-guided peptidomimetic design leads to nanomolar beta-hairpin inhibitors of the Tat-TAR interaction of bovine immunodeficiency virus. , 2007, Biochemistry.
[12] J. Puglisi,et al. Conformation of the TAR RNA-arginine complex by NMR spectroscopy. , 1992, Science.
[13] John A. Robinson. The Design, Synthesis and Conformation of Some New β-Hairpin Mimetics: Novel Reagents for Drug and Vaccine Discovery , 2000 .
[14] J. Karn,et al. Structure-based drug design targeting an inactive RNA conformation: exploiting the flexibility of HIV-1 TAR RNA. , 2004, Journal of molecular biology.
[15] John A. Robinson,et al. Structural mimicry of retroviral tat proteins by constrained beta-hairpin peptidomimetics: ligands with high affinity and selectivity for viral TAR RNA regulatory elements. , 2004, Journal of the American Chemical Society.
[16] D. Patel,et al. Concerted motions in HIV-1 TAR RNA may allow access to bound state conformations: RNA dynamics from NMR residual dipolar couplings. , 2002, Journal of molecular biology.
[17] B Tidor,et al. Arginine-mediated RNA recognition: the arginine fork , 1991, Science.
[18] A. Bax,et al. Protein backbone angle restraints from searching a database for chemical shift and sequence homology , 1999, Journal of biomolecular NMR.
[19] C. A. Theimer,et al. New applications of 2D filtered/edited NOESY for assignment and structure elucidation of RNA and RNA-protein complexes , 2004, Journal of biomolecular NMR.
[20] J. A. Jaeger,et al. An NMR study of the HIV-1 TAR element hairpin. , 1993, Biochemistry.
[21] J. Karn,et al. The structure of the human immunodeficiency virus type-1 TAR RNA reveals principles of RNA recognition by Tat protein. , 1995, Journal of molecular biology.
[22] John A. Robinson. The Design, Synthesis and Conformation of Some New β-Hairpin Mimetics: Novel Reagents for Drug and Vaccine Discovery , 2000 .
[23] Gabriele Varani,et al. NMR investigation of RNA structure , 1996 .
[24] A M Gronenborn,et al. Direct structure refinement against residual dipolar couplings in the presence of rhombicity of unknown magnitude. , 1998, Journal of magnetic resonance.
[25] M. Baba. Recent status of HIV-1 gene expression inhibitors. , 2006, Antiviral research.
[26] Christopher L. McClendon,et al. Reaching for high-hanging fruit in drug discovery at protein–protein interfaces , 2007, Nature.
[27] Gabriele Varani,et al. How binding of small molecule and peptide ligands to HIV-1 TAR alters the RNA motional landscape , 2009, Nucleic acids research.
[28] Gabriele Varani,et al. Rational design of inhibitors of HIV-1 TAR RNA through the stabilisation of electrostatic "hot spots". , 2004, Journal of molecular biology.
[29] B. Peterlin,et al. Controlling the elongation phase of transcription with P-TEFb. , 2006, Molecular cell.
[30] A. Kirschning,et al. TAR-RNA recognition by a novel cyclic aminoglycoside analogue , 2006, Nucleic acids research.
[31] Charles D Schwieters,et al. The Xplor-NIH NMR molecular structure determination package. , 2003, Journal of magnetic resonance.
[32] G. Varani,et al. Targeting RNA with small-molecule drugs: therapeutic promise and chemical challenges. , 2001, Accounts of chemical research.
[33] J. Williamson,et al. Solution structure of the HIV-2 TAR-argininamide complex. , 1997, Journal of molecular biology.